Chemistry:5-MeO-DiBF

Short description: Chemical compound

5-MeO-DiBF

Clinical data
Routes of administration	?
Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class A US: ?
Identifiers
IUPAC name N-[2-(5-Methoxy-1-benzofuran-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine
CAS Number	none
PubChem CID	125276632
ChemSpider	58191435
UNII	98H5PQ3THV
Chemical and physical data
Formula	C17H25NO2
Molar mass	275.392 g·mol−1
3D model (JSmol)	Interactive image
SMILES COC1=CC=C(OC=C2CCN(C(C)C)C(C)C)C2=C1
InChI InChI=1S/C17H25NO2/c1-12(2)18(13(3)4)9-8-14-11-20-17-7-6-15(19-5)10-16(14)17/h6-7,10-13H,8-9H2,1-5H3 Key:NBFMSQBTYHYVKP-UHFFFAOYSA-N

5-MeO-DiBF is a psychedelic that has been sold online as a designer drug and was first definitively identified in December 2015 by a forensic laboratory in Slovenia. It is thought to act as an agonist for the 5-HT_1A and 5-HT₂ family of serotonin receptors. It is related in structure to the psychedelic tryptamine derivative 5-MeO-DiPT, but with the indole nitrogen replaced by oxygen, making 5-MeO-DiBF a benzofuran derivative. It is several times less potent as a serotonin agonist than 5-MeO-DiPT and with relatively more activity at 5-HT_1A, but still shows strongest effects at the 5-HT₂ family of receptors.

Legal status

5-MeO-DiBF is not controlled under the 1971 Convention on Psychotropic Substances, so thus it has a legal grey area in many countries, but it's possible it could be illegal under so-called analogue acts if sold for human consumption.

See also

• Dimemebfe